Parsley for Anti-Inflammatory

Research suggests that parsley and its bioactive compounds — particularly the flavonoid apigenin, polyphenols such as quercetin and ferulic acid, and essential oil constituents — demonstrate anti-inflammatory properties across a range of laboratory and animal studies, with proposed mechanisms including suppression of inflammatory signaling pathways such as NF-κB, JAK1/STAT1, and NLRP3, as well as binding to pro-inflammatory proteins like TNF-α and IL-1β. Studies indicate these effects have been observed in models relevant to skin inflammation, intestinal inflammation, organ protection, and neuroinflammation, with some animal studies showing results comparable to reference anti-inflammatory drugs. The body of evidence currently consists almost entirely of in vitro cell studies, animal experiments, and narrative reviews — with no robust human clinical trials identified — which substantially limits how confidently any of these findings can be applied to people. While the overall direction of the available research is supportive, reviewers across multiple studies consistently note that significant research gaps remain and that well-designed human trials are needed before any conclusions about therapeutic efficacy can be drawn.